期刊文献+

结肠癌LS174细胞培养上清对树突状细胞诱导CTL杀伤效应的影响 被引量:1

下载PDF
导出
摘要 目的:观察结肠癌细胞对人单个核细胞源树突状细胞(DC)诱导的CTL杀伤效应的影响,探讨其在人体的免疫逃避机制.方法:人外周血分离单个核细胞以GM-CSF和IL-4培养DC,用结肠癌LS174细胞的提取物诱导DC,并激活T淋巴细胞抗肿瘤效应,在此不同过程中,体系中加入人结肠癌细胞系LS174的培养上清液.以正常培养体系为对照,通过计算细胞毒杀伤率检测不同条件下DC激活同种异体T淋巴细胞杀伤肿瘤细胞的能力.结果:LS174细胞培养上清液作为条件培养的DC,在DC培养的早期阶段对DC激活过程有明显的影响(在DC培养的第1d加入肿瘤培养上清组,第3d加入肿瘤培养上清组vs正常培养的DC组,DC培养第5d加入肿瘤培养上清组,DC激活T淋巴细胞过程加入肿瘤培养上清组,P<0.05).结论:肿瘤细胞分泌的某些物质可在DC培养的早期阶段影响肿瘤的免疫,这可能是肿瘤细胞逃避机体免疫监视的机制之一.
出处 《世界华人消化杂志》 CAS 北大核心 2005年第9期1131-1133,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献9

  • 1Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755-1766.
  • 2Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer 1997;70:706-715.
  • 3Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM,Nadaf S, Kavanaugh D, Carbone DP. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996;2:1096-1103.
  • 4朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 5李明松,袁爱力,张万岱,刘思德,吕爱民,周殿元.树突状细胞体外诱导抗肝癌免疫[J].世界华人消化杂志,1999,7(2):161-163. 被引量:28
  • 6Ahmad M, Rees RC, Ali SA. Escape from immunotherapy:possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother 2004;53:844-854.
  • 7Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003;15:138-147.
  • 8Espinoza-Delgado I. Cancer vaccines. Oncologist 2002;7(Suppl 3):20-33.
  • 9Steinbrink K, Jonuleit H, Muller G, Knop J, Schuler G, Enk AH.Interlukin-10-treated human dendritic cells induced a melanoma-antigen-specific anergy in CD8+T cells resulting in a failure to lyse tumor cells. Blood 1999;93:1634-1642.

共引文献117

同被引文献12

  • 1彭正,李荣,李力,张磊,金婷.自体树突状细胞体外增强肿瘤患者引流淋巴结细胞抗肿瘤活性的作用[J].细胞与分子免疫学杂志,2004,20(5):595-597. 被引量:10
  • 2李东复,王艳芬,杨春荣,申吉子,闫峻.肝癌细胞抗原负载树突状细胞激活TIL的抗肿瘤作用[J].中华肝胆外科杂志,2005,11(1):14-16. 被引量:2
  • 3郭建巍,秦力维,吕同德,杨霄鹏,刘斌,昌业伟.胃癌组织CD1α和survivin表达及临床意义[J].世界华人消化杂志,2005,13(12):1425-1428. 被引量:3
  • 4Santi AD.Lymph node matastases:the Important of the Microenvironment.Cancer 2000, 88:175-179
  • 5Cohen PA,Peng L,Kjaergaard J,Plautz GE,Finke JH,Koski GK,Czerniecki BJ,Shu S.T-cell adoptive therapy of tumors:mechanisms of improved therapeutic performance.Crit Rev Immunol 2001, 21:215-248
  • 6Almand B,Resser JR,Lindman B,Nadaf S,Clark JI,Kwon ED,Carbone DP,Gabrilovich DI.Clinical significance of defective dendritic cell differentiation in cancer.Clin Cancer Res 2000, 6:1755-1766
  • 7Pinedo HM,Buter J,Luykx-de Bakker SA,Pohlmann PR,van Hensbergen Y,Heideman DA,van Diest PJ,de Gruijl TD,van der Wall E.Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF:effect on tumour-draining lymph node dendritic cells.Eur J Cancer 2003, 39:1061-1067
  • 8Li Q,Yu B,Grover AC,Zeng X,Chang AE.Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.J Immunother 2002, 25:304-313
  • 9Li Q,Grover AC,Donald EJ,Carr A,Yu J,Whitfield J,Nelson M,Takeshita N,Chang AE.Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.J Immunol 2005,175:1424-1432
  • 10Dallal RM,Christakos P,Lee K,Egawa S,Son YI,Lotze MT.Paucity of dendritic cells in pancreatic cancer.Surgery 2002, 131:135-138

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部